Management of patients after ischemic stroke. Use of citicoline

Abstract

In ischemic stroke (IS) patients, preventive actions against recurrent IS are required on a permanent basis, including lifestyle changes, medication therapy (antihypertensive, antiplatelet and statin drugs) and, in some patients, surgical treatment (carotid endarterectomy, or stenting). Depending on the type of the neurological disorder, various rehabilitation programs are indicated which in most cases require physical and mental activation of the patient and can be combined with various medicines (treatment of spasticity, depression, cognitive impairment). Results of multicenter, placebo-controlled studies on the efficacy and safety of citicoline (Ceraxon) for IS are presented. Citicoline is said to have a definite advantage over other drugs commonly used in this country for acute IS and in the recovery period.

Keywords

• вторичная профилактика ишемического инсульта
• реабилитация при ишемическом инсульте
• цитиколин
• secondary prevention of ischemic stroke
• ischemic stroke rehabilitation
• citicoline